Are recombinant products really infection risk free?
Biological medicinal products can be manufactured from a variety of sources. Recombinant products are currently produced from extremely well characterised cells grown in vitro and priori pose the lowest risk of transmitting infection. Validated production processes make a major contribution to product safety however.